tiprankstipranks
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price & Analysis

200 Followers

SXTC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.56 - $9.38
Previous Close$1.68
Volume60.94K
Average Volume (3M)592.25K
Market Cap
$950.10K
Enterprise Value-$15.82M
Total Cash (Recent Filing)$17.37M
Total Debt (Recent Filing)$599.23K
Price to Earnings (P/E)-1.7
Beta1.29
Feb 01, 2021
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding565,534
10 Day Avg. Volume198,670
30 Day Avg. Volume592,247
Standard Deviation0.30
R-Squared0.03
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)0.06
Price to Sales (P/S)0.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-37.11
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.24%0.00%99.76%
0.00%
Insiders
0.00% Other Institutional Investors
99.76% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

SXTC FAQ

What was China SXT Pharmaceuticals Inc’s price range in the past 12 months?
China SXT Pharmaceuticals Inc lowest stock price was $1.56 and its highest was $9.38 in the past 12 months.
    What is China SXT Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is China SXT Pharmaceuticals Inc’s upcoming earnings report date?
    China SXT Pharmaceuticals Inc’s upcoming earnings report date is Feb 01, 2021 which is 1170 days ago.
      How were China SXT Pharmaceuticals Inc’s earnings last quarter?
      China SXT Pharmaceuticals Inc released its earnings results on Mar 28, 2019. The company reported $3.29 earnings per share for the quarter, beating the consensus estimate of N/A by $3.29.
        Is China SXT Pharmaceuticals Inc overvalued?
        According to Wall Street analysts China SXT Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does China SXT Pharmaceuticals Inc pay dividends?
          China SXT Pharmaceuticals Inc does not currently pay dividends.
          What is China SXT Pharmaceuticals Inc’s EPS estimate?
          China SXT Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does China SXT Pharmaceuticals Inc have?
          China SXT Pharmaceuticals Inc has 565,534 shares outstanding.
            What happened to China SXT Pharmaceuticals Inc’s price movement after its last earnings report?
            China SXT Pharmaceuticals Inc reported an EPS of $3.29 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of China SXT Pharmaceuticals Inc?
              Currently, no hedge funds are holding shares in SXTC
              ---

              Company Description

              China SXT Pharmaceuticals Inc

              China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Its product categories includes directly-oral, after-soaking-oral, fine, and regular TCMP. It distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Akari Therapeutics
              Aileron Therapeutics
              Oragenics
              ACADIA Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis